Stylish children's frames debut for back-to-school season

Article

Safilo offers stylish back-to-school options by releasing 15 new children's frames in its Carerra Kids, Chesterfield, Nine West, and Juicy Girls eyewear collections.

Key Points

Carrera Kids offers three new unisex metal frames (CA7490, CA7491, and CA7492) for kids and tweens. All styles have stainless-steel fronts combined with bridges and temples made of memory metal (Flexolite), as well as adjustable nose pads. CA7490 has a teacup shape and is available in black, light gunmetal, and brown. CA7491 and CA7492 feature oval shapes and are offered in black/blue, blue/tan, and matte brown. All three styles feature single bridges and adjustable nose pads.

Safilo, Parsippany, NJ; 800/631-1188 or http://www.safilousa.com/

Recent Videos
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Dr Paul Karpecki discusses atropine formulation from Sydnexis following NDA acceptance by FDA
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
OptiLIFT in action: Dr. Julie McLaughlin's experience with the new device
© 2025 MJH Life Sciences

All rights reserved.